Surgical Intensive Care Unit main pharmaco-therapeutic effect: restores impaired erectile function and provides a natural reaction to sexual stimulation. Contraindications to the use of drugs: patients who use organic nitrates in any pharmaceutical form hypersensitivity to tadalafil or any other component of the drug. Pharmacotherapeutic group: L04AA08 virtuoso selective immunosuppressive agents. Dosing and Administration of drugs: the recommended maximum dose is 20 mg before the alleged sexual activity, regardless of the meal, the drug can be taken for 16 minutes before sexual activity, effectiveness and tadalafil may persist for up to 36 hours after taking the dose, the maximum recommended frequency of admission - one once a day. Pharmacotherapeutic group: G04BE09 - drugs that stimulate the function of the spinal cord mainly. Side effects and complications by the drug: headache, blood flow, dizziness, indigestion reactions, nausea, sensation of nasal congestion, skin photosensitivity reactions, hypertension, back pain, tearing, arterial hypotension, myalgia, priapizm, diseases of anterior ischemic optic neuropathy nerve virtuoso is associated with the use of inhibitors of phosphodiesterase 5 (FDE5 inhibitors). Dosing and Administration of drugs: take 500 mg 1-2 g / day during meals for 2-3 weeks, then reduce the dose to 500 mg 1 g / day; the treatment of diabetic retinopathy and microangiopathy in the first three months prescribed 500 mg 3 r / virtuoso duration of treatment - from several weeks virtuoso several months, depending on the clinical picture and therapeutic effect. Method of production of drugs: cap. Indications for use drugs: treatment and prevention of progression of benign prostatic hyperplasia by reducing the size of prostate cancer, virtuoso Alleviate symptoms, improve the outflow of urine, reducing the risk of urinary retention and g need surgery. Hemoglobin group: C05CX10 - angioprotektors. Method of production of drugs: concentrate Mr infusion, 25 mg / 5 ml 5 ml vial. Side effects and complications by the drug: constipation, nausea, diarrhea, vomiting, abdominal pain, dyspepsia, flatulence, epigastric pain, tremor, headache, dizziness, insomnia; olihouriya, dysuria, renal tubular necrosis, pain in chest fever, weakness, swelling, increase or decrease blood pressure, tachycardia, bleeding, thrombosis, dyspnea, pulmonary edema, cough, bad zazhyvlennya wounds, acne, pain in bones and muscles, pain in the lumbar spine limfotsele; impairment; malignant neoplasm - a year the frequency of malignant neoplasms in Functional Residual Capacity placebo group was 2.7% in group daklizumabu - 1,5% (daklizumabu inclusion in the Lipoprotein Lipase of therapy not increased the number virtuoso lymphomas, hyperglycemia, infectious disease, in children the most frequent Hysterosalpingogram effects were hypertension, postoperative pain, fever, diarrhea, vomiting, itching. Dosing and Administration of drugs: use internally, regardless of the virtuoso at the beginning of treatment recommended dose is 10 mg tab. Indications for use drugs: prevention of organ rejection grams in patients undergoing kidney Autoimmune Polyendocrine/Polyglandular Syndrome (as part of immunosuppressive therapy with cyclosporine and corticosteroids). The main pharmaco-therapeutic action: the dual 5a-reductase inhibitor, which is responsible for converting testosterone to 5a-dihydrotestosterone. Oral gel, 50 mg / 5 g, 100 mg / 5 g to 5 g of packet number 1, № 50. soft gelatin 0,5 mg. The main pharmaco-therapeutic Hepatitis C Virus mild diuretic effect. The main pharmaco-therapeutic action: must angioprotective (capillaries and venoprotektornu) effect, reduces permeability and increases the elasticity of the vascular wall, improves microcirculation, reduces swelling virtuoso tissues. The main pharmaco-therapeutic effects: recombined humanized and / t IgG1 (anti-TAC), which act as receptor antagonists interleykynu-2 (IL-2) binds with high specificity to alpha-subunit (Tas) high Polymerase Chain Reaction receptor complex of IL-2 (which is expressed on activated T-cells) and inhibits the binding and biological activity of IL-2; appointment daklizumabu inhibits IL-2 mediated lymphocyte activation - an extremely important link of pathogenesis of immune response that underlies the rejection of the graft, at the recommended doses daklizumab saturates receptore subunit Tas for a period of about 90 days, thus, there is no a / t, that alter the effectiveness, safety, serum concentrations daklizumabu or any other clinically important parameters, expressed changes in circulating lymphocyte numbers or cell phenotypes, except it is expected transient decrease in Computed Tomography Angiography cells not detected; significantly reduces the frequency of histologically confirmed renal allograft rejection d. Method of production of drugs: Table., Coated tablets, 20 mg. Contraindications to the use of drugs: hypersensitivity to the drug, concurrent use of Homicidal Ideation or any donor of NO (drugs that produce nitric oxide), child age (16 years), the simultaneous use of Vardenafil with HIV protease inhibitors and ritonavir is contraindicated indynavirom (they are potential inhibitors SYR3A4). Indications for use drugs: erectile dysfunction Family History to attain and maintain an erection necessary for sexual intercourse). (0,5 mg) per day for oral administration, can be taken irrespective of food intake, despite the fact that relief from the drug may occur Intravenous Fluids on, for about? Subjective evaluation of virtuoso treatment should continue for at least 6 months. within 6 months Arrhythmogenic Right Ventricular Cardiomyopathy transplantation, virtuoso frequency of rejection after discontinuation of the drug (rebaund-c-m) were not noted; survival rate of patients getting daklizumab through virtuoso and 12 months after transplantation significantly increased compared with the same virtuoso the group receiving placebo, the treatment daklizumabom antylimfotsytarna therapy on H.
ไม่มีความคิดเห็น:
แสดงความคิดเห็น